Consistent with our previous findings, J10 treatment effectively decreased DDX3X protein levels (Fig. 7H) and showed comparable cytotoxicity with RK-33 in pancreatic cancer and colon cancer (Fig. 7I, J). Here, DDX3X is linked to pancreatic neoplasm.